These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 22166435)

  • 1. Presymptomatic Parkinson's disease: the Arizona experience.
    Caviness JN
    Parkinsonism Relat Disord; 2012 Jan; 18 Suppl 1():S203-6. PubMed ID: 22166435
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence that incidental Lewy body disease is pre-symptomatic Parkinson's disease.
    Dickson DW; Fujishiro H; DelleDonne A; Menke J; Ahmed Z; Klos KJ; Josephs KA; Frigerio R; Burnett M; Parisi JE; Ahlskog JE
    Acta Neuropathol; 2008 Apr; 115(4):437-44. PubMed ID: 18264713
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential spectral quantitative electroencephalography patterns between control and Parkinson's disease cohorts.
    Caviness JN; Utianski RL; Hentz JG; Beach TG; Dugger BN; Shill HA; Driver-Dunckley ED; Sabbagh MN; Mehta S; Adler CH
    Eur J Neurol; 2016 Feb; 23(2):387-92. PubMed ID: 26518336
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alpha-synuclein pathology in Parkinson's and Alzheimer's disease brain: incidence and topographic distribution--a pilot study.
    Jellinger KA
    Acta Neuropathol; 2003 Sep; 106(3):191-201. PubMed ID: 12845452
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical criteria for the diagnosis of Parkinson's disease.
    Reichmann H
    Neurodegener Dis; 2010; 7(5):284-90. PubMed ID: 20616563
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Upregulation of the anti-apoptotic protein Bcl-2 may be an early event in neurodegeneration: studies on Parkinson's and incidental Lewy body disease.
    Marshall KA; Daniel SE; Cairns N; Jenner P; Halliwell B
    Biochem Biophys Res Commun; 1997 Nov; 240(1):84-7. PubMed ID: 9367887
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Parkinsonian features of eight pathologically diagnosed cases of diffuse Lewy body disease.
    Louis ED; Goldman JE; Powers JM; Fahn S
    Mov Disord; 1995 Mar; 10(2):188-94. PubMed ID: 7753061
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidental Lewy body disease: electrophysiological findings suggesting pre-clinical Lewy body disorders.
    Caviness JN; Adler CH; Hentz JG; Shill HA; Evidente VG; Driver-Dunckley ED; Sabbagh MN; Sue L; Beach TG
    Clin Neurophysiol; 2011 Dec; 122(12):2426-32. PubMed ID: 21616709
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of a screening questionnaire for genetic studies of Parkinson's disease.
    Racette BA; Rundle M; Parsian A; Perlmutter JS
    Am J Med Genet; 1999 Oct; 88(5):539-43. PubMed ID: 10490713
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diminished tyrosine hydroxylase immunoreactivity in the cardiac conduction system and myocardium in Parkinson's disease: an anatomical study.
    Ghebremedhin E; Del Tredici K; Langston JW; Braak H
    Acta Neuropathol; 2009 Dec; 118(6):777-84. PubMed ID: 19802627
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Subthalamic GAD gene transfer in Parkinson disease patients who are candidates for deep brain stimulation.
    During MJ; Kaplitt MG; Stern MB; Eidelberg D
    Hum Gene Ther; 2001 Aug; 12(12):1589-91. PubMed ID: 11529246
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of risk factor profiles in incidental Lewy body disease and Parkinson disease.
    Frigerio R; Fujishiro H; Maraganore DM; Klos KJ; DelleDonne A; Heckman MG; Crook JE; Josephs KA; Parisi JE; Boeve BF; Dickson DW; Ahlskog JE
    Arch Neurol; 2009 Sep; 66(9):1114-9. PubMed ID: 19752300
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased risk of leg motor restlessness but not RLS in early Parkinson disease.
    Gjerstad MD; Tysnes OB; Larsen JP
    Neurology; 2011 Nov; 77(22):1941-6. PubMed ID: 22076542
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuroleptic sensitivity in Parkinson's disease and parkinsonian dementias.
    Aarsland D; Perry R; Larsen JP; McKeith IG; O'Brien JT; Perry EK; Burn D; Ballard CG
    J Clin Psychiatry; 2005 May; 66(5):633-7. PubMed ID: 15889951
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A longitudinal program for biomarker development in Parkinson's disease: a feasibility study.
    Ravina B; Tanner C; Dieuliis D; Eberly S; Flagg E; Galpern WR; Fahn S; Goetz CG; Grate S; Kurlan R; Lang AE; Marek K; Kieburtz K; Oakes D; Elliott R; Shoulson I;
    Mov Disord; 2009 Oct; 24(14):2081-90. PubMed ID: 19691116
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Incidental occurrence of Lewy bodies in the brains of elderly patients--the relevance to aging and Parkinson's disease].
    Wakabayashi K; Takahashi H; Oyanagi K; Ikuta F
    No To Shinkei; 1993 Nov; 45(11):1033-8. PubMed ID: 8135950
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incidental Lewy body disease: clinical comparison to a control cohort.
    Adler CH; Connor DJ; Hentz JG; Sabbagh MN; Caviness JN; Shill HA; Noble B; Beach TG
    Mov Disord; 2010 Apr; 25(5):642-6. PubMed ID: 20175211
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is pre-motor diagnosis possible? The European experience.
    Berg D
    Parkinsonism Relat Disord; 2012 Jan; 18 Suppl 1():S195-8. PubMed ID: 22166433
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Axonal alpha-synuclein aggregates herald centripetal degeneration of cardiac sympathetic nerve in Parkinson's disease.
    Orimo S; Uchihara T; Nakamura A; Mori F; Kakita A; Wakabayashi K; Takahashi H
    Brain; 2008 Mar; 131(Pt 3):642-50. PubMed ID: 18079166
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Parkinson's disease dementia: definitions, guidelines, and research perspectives in diagnosis.
    Goetz CG; Emre M; Dubois B
    Ann Neurol; 2008 Dec; 64 Suppl 2():S81-92. PubMed ID: 19127578
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.